2 days ago
INDV
AnalystsDavid AmsellemDavid Amsellem's Stock Forecasts
AnalystsDavid Amsellem
Analyst Ranking
Top 7%
#323 out of 5087 analysts
Average Return
+16.11%
Win Rate
62%76 out of 122
Risk vs Reward
Poor
Good
David Amsellem's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amneal Pharmaceuticals IncAMRX | +222.28% | $2.02 | $6.51 | 2023-05-08 - 2024-05-07 | Strong Buy |
Indivior PLCINDV | +218.77% | $7.46 | $23.78 | 2024-10-11 - 2025-10-10 | Strong Buy |
Indivior PLCINDV | +196.97% | $9.89 | $29.37 | 2025-03-06 - 2025-10-31 | Strong Buy |
Horizon Therapeutics Public Ltd CoHZNP | +189.77% | $31.56 | $91.45 | 2020-04-14 - 2021-04-14 | Strong Buy |
Indivior PLCINDV | +179.22% | $9.00 | $25.13 | 2024-10-25 - 2025-10-24 | Strong Buy |
David Amsellem Analyst Color
Get additional color on David Amsellem's coverage of popular stocks
2 days ago
AMRX
4 days ago
NBIX
24 days ago
SUPN
3 months ago
NBIX
7 months ago
CORT
8 months ago
CORT
10 months ago
TEVA
a year ago
AMRX
a year ago
INDV
a year ago
CORT
a year ago
NBIX
a year ago
CORT
2 years ago
AMRX
2 years ago
JAZZ
2 years ago
IRWD
2 years ago
TEVA
2 years ago
AVDL
2 years ago
AXSM
2 years ago
AMRX
2 years ago
CORT
2 years ago
IRWD
2 years ago
SUPN
3 years ago
RVNC
3 years ago
SUPN
David Amsellem's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Indivior PLCINDV | 6 | Strong Buy | $41.00 | +39.60% | Reiterates | 2 days ago |
Amneal Pharmaceuticals IncAMRX | 5 | Strong Buy | $13.00 | +20.15% | Reiterates | 2 days ago |
Neurocrine Biosciences IncNBIX | 9 | Strong Buy | $179.00 | +24.99% | Maintains | 4 days ago |
Alkermes PLCALKS | 8 | Strong Buy | $45.00 | +46.58% | Reiterates | 10 days ago |
Supernus Pharmaceuticals IncSUPN | 12 | Strong Buy | $65.00 | +17.90% | Upgrades | 24 days ago |
Amgen IncAMGN | 5 | Strong Buy | $342.00 | +14.60% | Maintains | 2 months ago |
Biogen IncBIIB | 2 | Hold | $118.00 | -23.51% | Maintains | 3 months ago |
Abbvie IncABBV | 1 | Strong Buy | $231.00 | +5.94% | Assumes | 3 months ago |
Amphastar Pharmaceuticals IncAMPH | 8 | Hold | $25.00 | -1.96% | Maintains | 3 months ago |
Corcept Therapeutics IncCORT | 8 | Strong Buy | $121.00 | +64.69% | Maintains | 3 months ago |
Sage Therapeutics IncSAGE | 2 | Hold | $8.50 | -2.07% | Downgrades | 5 months ago |
Organon & CoOGN | 6 | Strong Buy | $18.00 | +166.67% | Maintains | 6 months ago |
Collegium Pharmaceutical IncCOLL | 7 | Hold | $37.00 | +2.78% | Reiterates | 6 months ago |
Jazz Pharmaceuticals PLCJAZZ | 9 | Strong Buy | $147.00 | +6.80% | Reiterates | 6 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $65.00 | +41.09% | Initiates Coverage On | 6 months ago |
Optinose IncOPTN | 3 | Hold | $9.00 | -6.25% | Downgrades | 7 months ago |
Xeris Biopharma Holdings IncXERS | 5 | Hold | $4.00 | -58.76% | Reiterates | 8 months ago |
Viatris IncVTRS | 7 | Hold | $10.00 | -3.47% | Reiterates | 8 months ago |
Teva Pharmaceutical Industries LtdTEVA | 7 | Strong Buy | $30.00 | +46.48% | Maintains | 10 months ago |
Intra Cellular Therapies IncITCI | 1 | Hold | $132.00 | +0.10% | Downgrades | 10 months ago |
Avadel Pharmaceuticals PLCAVDL | 4 | Strong Buy | $13.00 | -31.18% | Maintains | 10 months ago |
Ani Pharmaceuticals IncANIP | 1 | Strong Buy | $68.00 | N/A | Initiates Coverage On | a year ago |
Revance Therapeutics IncRVNC | 7 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Bausch Health Companies IncBHC | 4 | Strong Sell | $3.00 | N/A | Downgrades | a year ago |
Pacira Biosciences IncPCRX | 7 | Strong Buy | $42.00 | N/A | Maintains | a year ago |
Aquestive Therapeutics IncAQST | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Ironwood Pharmaceuticals IncIRWD | 3 | Strong Buy | $21.00 | N/A | Maintains | 2 years ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $113.00 | N/A | Maintains | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $45.00 | N/A | Downgrades | 2 years ago |
Tvardi Therapeutics IncTVRD | 3 | Hold | $12.00 | N/A | Downgrades | 2 years ago |
Harmony Biosciences Holdings IncHRMY | 3 | Strong Buy | $42.00 | N/A | Maintains | 2 years ago |
Eagle Pharmaceuticals IncEGRX | 2 | Strong Sell | $17.00 | N/A | Downgrades | 2 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $285.00 | N/A | Initiates Coverage On | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 3 | Strong Buy | $110.00 | N/A | Maintains | 3 years ago |
Antares Pharma IncATRS | 1 | Hold | $5.60 | N/A | Downgrades | 4 years ago |
Endo International PLCENDPQ | 3 | Hold | $3.00 | N/A | Maintains | 4 years ago |
Biodelivery Sciences International IncBDSI | 1 | Hold | $5.60 | N/A | Downgrades | 4 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Hold | $8.00 | N/A | Downgrades | 4 years ago |
Evofem Biosciences IncEVFM | 1 | Strong Buy | $165.00 | N/A | Initiates Coverage On | 5 years ago |
Impax Laboratories IncIPXL | 1 | Hold | N/A | N/A | Upgrades | 8 years ago |
Societal Cdmo IncSCTL | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.